搜索
Search
这是描述信息

News Center

Yin Li , Director of SFDA Visited Livzon Group

  • Categories:Livzon News
  • Author:
  • Origin:
  • Time of issue:2012-12-03 17:42
  • Views:

(Summary description)Yin Li , Director of SFDA Visited Livzon Group

Yin Li , Director of SFDA Visited Livzon Group

(Summary description)Yin Li , Director of SFDA Visited Livzon Group

  • Categories:Livzon News
  • Author:
  • Origin:
  • Time of issue:2012-12-03 17:42
  • Views:
Information

"As a corporation set up after reform and opening up policy, Livzon forms its present scale and pattern after about 30 years development and growth, and in the future, it must be stronger, surpass other corporations in the same circle at home and catch up with the top pharmaceutical companies in the worldwide. Just as CEO, Mr. Zhu said, it is very difficult to make breakthroughs and innovations in the area that has been in the dominant position for hundreds of years, the chemical area and the biological engineering is just at its best time in the international market, Livzon's transformation to the area shows its forwark-looking awareness and strategical version and indicates the future success of Livzon." This is what Yin Li, Director of SFDA said with Zhu Baoguo, Chairman and CEO of Livzon Group.

Continue to Mr. Yin Li's topic, Mr. Zhu Baoguo, the chairman of Livzon Group said "Drug research and development, as a long accumulative process, can not be operated too fast and can not be successful only by rolling up sleeves just as the Giant Leap, for it contains some precision scientific system such as biology and genetics. I visited Merck, where I got some latest information and found not only Livzon but also the whole pharmaceutical field can hardly break the bottle neck of the chemical drug, which is the reason that I turned to bio-drug field and chose monoclonal antibody. I had considered starting the project since 1999, however the opportunity didn't arrive until 2010. Up to now, 7 products have been developed, one of which has been applied for clinical trials"

Yin Li was very happy and regarded it as the great news for patients.

Yin Li, the Director visited Livzon for research and investigation on Nov. 29 with the companion of some other SFDA members, Director of Guangdong FDA, Chen Yuancheng, Mayor of Zhuhai City, He Ningka.

Zhu Baoguo, chairman and CEO of Livzon Group, An Ning, the Executive VP, Tao Desheng and Lu Wenqi, two VPs and Doc. Fu Daotian, the Deputy General Manager introduced the development history of Livzon, the major area and cor products and their great achievement in market.

He Kaning, the mayor expressed his appreciation proudly "As a renowned company, Livzon, has been developed rapidly and steadily. Its research and development team is not only the elite of Livzon, but also the honor of Zhu Hai. "

Mr. Yin Li, the director also voiced his opinion on pharmaceutical industry and the drug quality "With the rapid development of economy, the continuously improvement of life standard, people requires more and more healthcare, higher and higher life quality, and their demands for drug will increase continuously, which fundamentally drives the development of the drug industry. As a result, the whole society focuses much attention on drug quality, and ensuring the safety and efficacy of drug have been the top task of all the pharmaceutical corporations and regulatory authorities. The drugs of your company can sell well only when they are all safe, effect and reliable. "

"According to the result of a research on drug quality performed by an international corporation in 2005, drugs produced by Livzon and Bristol-Myers Squibb possess the best quality among pharmaceutical companies at home and overseas respectively." Mr. Zhu Baoguo said proudly " We have a very clear philosophy: Every thing and every one must give way to quality in any case. We must meet 100% of the requirement regarding quality, even 0.1% derivation may threat the health and life of the users, and nobody can bear the responsibility. "

In Yin Li's words "It is the general rule of the world to manage the drug products strictly. And we should publize this more to strengthen the confidence to national drug, to popularize scientific knowledge and to lead healthy lifestyle and concept transformation. "

At last, Yin Li expressed his hope that livzon could learn from the past experiences and develop more effectively and steadily and could prosper together with the society.

Chairman, Zhu Baoguo was very gratitude to Yin Li's visit and sent him the documentation of Shenqifuzheng Injection as present.

Keyword:

There is currently no information to display
Please add data record on website background.

SAUNDERS

WRITE A MESSAGE TO US

留言应用名称:
不良报告
描述:

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn